MBNL1 and myotonic dystrophy type 1: Additionally we found improvement in skeletal muscle myotonia and splicing defects after over-expression of MBNL1, revealing the possible role of MBNL1 deficiency in the pathology of these mice and also demonstrating the potential of this mouse model for testing compounds aimed at treating the disease phenotypes associated with DM1.